Israel Biotech Fund II, L.P. — Form D
Israel Biotech Fund II, L.P. of REHOVOT, L3, a pooled investment fund, filed a Form D exempt-offering notice with the SEC on 2019-07-24. The offering totals $100.0M, of which $65.0M was reported sold. Industry: Pooled Investment Fund.
Offering
- Filed: 2019-07-24
- Form: D
- Accession: 0001782947-19-000002
- Industry: Pooled Investment Fund
- Exemptions: 06b, 3C, 3C.7
- Total offering: $100.0M
- Amount sold: $65.0M
- Remaining: $35.0M
- Investors: 44
- Date of first sale: 2019-07-09
- Security types: fund interests
- Revenue range: Decline to Disclose
- SEC file number: 021-344933
Issuer
- Name: Israel Biotech Fund II, L.P.
- CIK: 0001782947
- Entity type: Limited Partnership
- Jurisdiction: CAYMAN ISLANDS
- Incorporated: 2019
- Address: PEKERIS 3, REHOVOT, L3, 670203
- Phone: 972-72-251-4175
Officers, directors & promoters (3)
| Name | Role | Location |
|---|
| Yuval Cabilly | Executive Officer | Rehovot, L3 |
| David Sidransky | Executive Officer | Germantown, MD |
| Ido Zairi | Executive Officer | Rehovot, L3 |
More